Evidence map›Paper›PMID 30237260›Full record

ArticleHaematologica2019

Bone marrow mesenchymal stem/stromal cells from risk-stratified acute myeloid leukemia patients are anti-inflammatory in

Rafael Diaz de la Guardia, Belen Lopez-Millan, Heleia Roca-Ho, Clara Bueno, Francisco Gutiérrez-Agüera, Jose Luis Fuster, Eduardo Anguita, Samanta Romina Zanetti, Susana Vives, Josep Nomdedeu and 6 more

Open access · goldAbstract readLetter
In one paragraph

Article in Haematologica, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. High-efficient generation of VCAM-1Cell proliferation · 2020
    Article
  9. Article
  10. Article
  11. Role of Stem-Cell Transplantation in Leukemia Treatment.Stem cells and cloning : advances and applications · 2020
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 3 countries.

Rafael Diaz de la GuardiaJosep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Spain.
Belen Lopez-MillanJosep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Spain.
Heleia Roca-HoJosep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Spain.
Clara BuenoJosep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Spain.
Francisco Gutiérrez-AgüeraJosep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Spain.
Jose Luis FusterSección de Oncohematología Pediátrica, Hospital Virgen de Arrixaca, Murcia, Spain.
Eduardo AnguitaServicio de Hematología, Hospital Clínico San Carlos, IdISSC, Medicina UCM, Madrid, Spain.
Samanta Romina ZanettiJosep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Spain.
Susana VivesHematology Department, ICO-Hospital Germans Trias i Pujol and Josep Carreras Leukemia Research Institute, Barcelona, Spain.
Josep NomdedeuServicio de Hematología, Hospital de la Santa Creu i Sant Pau and Josep Carreras Leukemia Research Institute, Barcelona, Spain.
Robert SacksteinDepartment of Medicine and Program of Excellence in Glycosciences, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Jessie LavoieBiologics and Genetic Therapies Directorate, Health Products and Food Branch, Health Canada, Ottawa, ON, Canada.
Elena Gónzalez-ReyInstituto de Parasitología y Biomedicina López-Neyra, CSIC, Granada, Spain.
Mario DelgadoInstituto de Parasitología y Biomedicina López-Neyra, CSIC, Granada, Spain.
Michael Rosu-MylesBiologics and Genetic Therapies Directorate, Health Products and Food Branch, Health Canada, Ottawa, ON, Canada.
Pablo MenendezJosep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Spain pmenendez@carrerasresearch.org.
Josep Carreras Leukaemia Research Institute · ESUniversitat de Barcelona · ESHealth Canada · CAInstituto de Parasitología y Biomedicina "López - Neyra" · ESHarvard University · USHospital Universitario Virgen de la Arrixaca · ESInstituto de Investigación Sanitaria del Hospital Clínico San Carlos · ES

Funding

REGULATION OF LACTOSAMINYL GLYCAN BIOSYNTHESIS IN HEMATOPOIETIC CELLSP01HL107146 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SACKSTEIN, ROBERT · 2011 to 2017
$17.7M
European Research Council 646903NHLBI NIH HHS P01 HL107146
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HematopoiesisMesenchymal Stem Cell TransplantationAnimalsColitisDisease Models, AnimalHumansLeukemia, Myeloid, AcuteMesenchymal Stem CellsMiceSeverity of Illness IndexTreatment Outcome

Identifiers

PMID30237260
PMCPMC6355484
OpenAlexW2890347208

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.